Journal article
STAT3 in tissue fibrosis: Is there a role in the lung?
Pulmonary Pharmacology & Therapeutics, Vol.24(2), pp.193-198
2011
Abstract
Fibrosis is defined as an excessive deposition of connective tissue components that results in the destruction of normal tissue architecture and compromises organ function. When fibrosis occurs in the major organs such as the lung, for example in idiopathic pulmonary fibrosis, it inevitably leads to organ failure and premature death of the afflicted individual. Current evidence suggests that fibrosis initially develops along the same pathway as normal wound healing, although there is chronic progression of the disease without resolution, suggesting the control of intracellular processes that occur during wound healing is disturbed. It follows then that determining where this control is lost is key to preventing and treating this condition. The IL-6 cytokine family is a group of pleiotropic cytokines produced by a variety of cells in response to inflammatory stimuli. These cytokines are grouped together on the basis of overlapping functions, and common usage of gp130 as part of their multimeric receptor complexes. Activation of these receptor complexes results in the recruitment and phosphorylation of the latent transcription factor STAT-3 which induces a gene program involved in cell differentiation and proliferation. STAT3 also induces expression of a number of inhibitors including SOCS-3. In this manuscript we review the available literature on the IL-6/gp-130 family of cytokines and their role in regulating fibrosis. Despite a large number of studies in mouse models as well as human cells in vitro, the role of these cytokines or STAT3 activated by other cytokines in the development of fibrosis remains unclear.
Details
- Title
- STAT3 in tissue fibrosis: Is there a role in the lung?
- Authors/Creators
- D. Knight (Author/Creator) - University of British ColumbiaS.E. Mutsaers (Author/Creator) - School of Medicine and PharmacologyC.M. Prêle (Author/Creator) - The University of Western Australia
- Publication Details
- Pulmonary Pharmacology & Therapeutics, Vol.24(2), pp.193-198
- Publisher
- Elsevier Ltd
- Identifiers
- 991005540414107891
- Copyright
- © 2010 Elsevier Ltd.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
27 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.6 Immunology
- 1.6.1264 STAT3 Signaling
- Web Of Science research areas
- Pharmacology & Pharmacy
- Respiratory System
- ESI research areas
- Clinical Medicine